Bayer AG

BAYRY

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
46,606
Cost of Revenue
21,270
Gross Profit
25,336
Gross Margin
54.4%
Operating Income
3,327
Operating Margin
7.1%
Net Income
-2,552
Net Margin
-5.5%
EPS (Basic)
$-0.65
EPS (Diluted)
$-0.65
EBITDA
8,807
EBITDA Margin
18.9%

2023

12/31/2023

Revenue
47,637
Cost of Revenue
19,749
Gross Profit
27,888
Gross Margin
58.5%
Operating Income
-150
Operating Margin
-0.3%
Net Income
-2,941
Net Margin
-6.2%
EPS (Basic)
$-0.75
EPS (Diluted)
$-0.75
EBITDA
4,209
EBITDA Margin
8.8%

2022

12/31/2022

Revenue
50,739
Cost of Revenue
19,871
Gross Profit
30,868
Gross Margin
60.8%
Operating Income
6,264
Operating Margin
12.3%
Net Income
4,150
Net Margin
8.2%
EPS (Basic)
$1.06
EPS (Diluted)
$1.06
EBITDA
10,443
EBITDA Margin
20.6%

2021

12/31/2021

Revenue
44,081
Cost of Revenue
16,816
Gross Profit
27,265
Gross Margin
61.9%
Operating Income
6,975
Operating Margin
15.8%
Net Income
1,000
Net Margin
2.3%
EPS (Basic)
$0.26
EPS (Diluted)
$0.26
EBITDA
6,968
EBITDA Margin
15.8%

2020

12/31/2020

Revenue
41,400
Cost of Revenue
19,138
Gross Profit
22,262
Gross Margin
53.8%
Operating Income
-2,939
Operating Margin
-7.1%
Net Income
-15,561
Net Margin
-37.6%
EPS (Basic)
$-3.96
EPS (Diluted)
$-3.96
EBITDA
-11,480
EBITDA Margin
-27.7%